Gauss Surgical Completes $12 Million Series A Financing; Proceeds to Propel Commercial Growth of World’s First Mobile Platform to Monitor Surgical Blood Loss
Company Hires New Vice President of Sales to Accelerate Customer Acquisition
Los Altos, Calif. -- Gauss Surgical, Inc. announced today that the company has completed series A financing to accelerate sales growth and further commercialization of the Triton System™, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. The latest round was led by Promus Ventures and joined by Summation Health Ventures and LifeForce Ventures.
“As prior investors in the Gauss team, we recognized that they have the right combination of experience, vision and technology to bring this novel platform to the commercial mainstream,” said Mike Collett, General Partner at Promus Ventures, who will be joining the Gauss Surgical Board as an Observer. “Blood management has the potential to deliver better patient outcomes while reducing healthcare costs and surgical risk. Gauss has already developed significant customer momentum and we are excited to help propel this exciting phase of growth.”
“We are thrilled at the caliber of investors who continue to support our vision at Gauss,” said Siddarth Satish, Chairman, Founder, and Chief Technology Officer. “This next period will further enable us to technologically advance blood management as a patient safety issue, while allowing us to fundamentally reframe patient monitoring as a services and solutions business.”
As part of Gauss Surgical’s commercialization strategy, the company has hired J. Scott Ashworth as Vice President of Sales. Ashworth brings more than 25 years of experience in building and leading global sales and marketing teams focused on commercialization of products and establishing distribution partnerships. In his new role, Ashworth will focus on driving customer acquisition.
“As we embark on this pivotal phase in the commercialization of the Triton System, we are excited to have someone of Scott’s caliber join our team,” said Milton B. McColl, M.D., Chief Executive Officer of Gauss Surgical. “His extensive background in International medical technology sales will be an asset in growing our business both domestically and globally.”
Prior to joining Gauss Surgical, Ashworth served in executive sales roles at three medical device start-ups including Avinger (NASDAQ: AVGR) and Heartflow. Previously, Ashworth was Vice President of Worldwide Sales and Service at Siemens Healthcare and held various leadership roles at Hewlett Packard Medical in sales and business development functions across the United States and Asia Pacific.
The Triton System leverages mobile technology in combination with cloud computing. Using the iPad’s camera, the system scans surgical sponges and canisters, and sends the images to the cloud where sophisticated algorithms estimate surgical blood loss in real-time. Triton, which is both FDA-cleared and HIPAA compliant, features an intuitive iPad interface, requires minimal training, and seamlessly integrates into surgical workflow. The technology is being implemented at Cedars-Sinai Medical Center, UC Irvine Healthcare, the Memorial Care Health System, and other leading health systems across the United States.
-
Most popular related searches
Related news
-
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors
Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023. Mr. Scannell joined Synaptive Medical’s Board of Directors in August 2022, bringing a wealth of experience and expertise in the medical device industry. Prior to joining the Board at Synaptive, Mr. Scannell served as President and Chief Operating Officer of Stryker...
-
Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities
Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome challenges such as accessibility in critical and acute cases like brain tumour and stroke, enabling healthcare professiona...
-
Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients
Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with Hydrocephalus Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce the successful first implant of the Company’s...
-
Best HIFU ultrasound facelift machine for medical aesthetic
Today, the medical aesthetic industry has developed to make people more comfortable and safe in their pursuit of beauty. Among the many medical aesthetic procedures available, the best HIFU machine professional is a popular one. It is based on high intensity focused ultrasound technology and provides amazing aesthetic results. This article will reveal the magic of HIFU in a number of sections. Bvlaser is a ODM face lift HIFU machine manufacturer, we have HIFU vaginal tightening machine for sale. Principles of...
-
Analysis of the cryolipolysis slimming machine advantages and disadvantages
Cryolipolysis is a medical aesthetic technique that uses freezing to break down excess fat in the body to achieve a slimming effect. This technique has a great popularity and many people feel confident and beautiful because of the success of this technique to lose weight. As we all know, the medical aesthetic industry has always been a hot industry and cryolipolysis beauty machine as a technique in the medical aesthetic industry, is also very popular in the current medical aesthetic field. Bvlaser is the best...
Customer comments
No comments were found for Gauss Surgical Completes $12 Million Series A Financing; Proceeds to Propel Commercial Growth of World’s First Mobile Platform to Monitor Surgical Blood Loss. Be the first to comment!